The central autonomic network (CAN) is a distributed brain system that coordinates autonomic functions including heart rate, blood pressure, respiration, digestion, pupillary response, and thermoregulation. This network integrates sensory information from internal organs (visceral afferents) with cognitive, emotional, and behavioral states to generate appropriate autonomic responses[@benarroch1993][@saper2002].
The CAN is particularly vulnerable in Parkinson's disease and multiple system atrophy, where alpha-synuclein pathology affects both central and peripheral autonomic pathways. Understanding CAN dysfunction is essential for comprehending the non-motor symptoms of these neurodegenerative disorders, which often precede motor manifestations by years or even decades[@jain2012][@kim2018].
flowchart TD
A["Medial Prefrontal<br/>Cortex"]
B["Anterior Cingulate<br/>Cortex"]
C["Insula"]
D["Amygdala"]
E["Hypothalamus"]
F["Periaqueductal<br/>Gray"]
G["Nucleus Tractus<br/>Solitarius"]
H["Dorsal Motor<br/>Nucleus Vagus"]
I["Ventrolateral<br/>Medulla"]
J["Spinal Cord<br/>Sympathetic"]
A --> B
B < --> C
C < --> D
D --> E
E --> F
F --> G
F --> H
F --> I
G --> H
I -->|"sympathetic"| J
style A fill:#bbdefb,stroke:#333
style B fill:#bbdefb,stroke:#333
style C fill:#c8e6c9,stroke:#333
style D fill:#ffcdd2,stroke:#333
style E fill:#c8e6c9,stroke:#333
style F fill:#c8e6c9,stroke:#333
style G fill:#c8e6c9,stroke:#333
style H fill:#c8e6c9,stroke:#333
style I fill:#c8e6c9,stroke:#333
The cortical component of the CAN includes the medial prefrontal cortex (mPFC), anterior cingulate cortex (ACC), and posterior insula. These regions process interoceptive information—the sense of the internal state of the body—and translate it into autonomic responses[@critchley2005].
- Medial Prefrontal Cortex: Top-down regulation of autonomic responses, emotional processing, and decision-making related to threat and reward
- Anterior Cingulate Cortex: Conflict monitoring, pain perception, and autonomic adjustment during cognitive challenges
- Insula: Primary interoceptive cortex, integrating visceral sensations with emotional awareness
The amygdala and hypothalamus form the limbic integration layer:
- Amygdala: Processes emotional significance of stimuli and triggers autonomic responses to fear, stress, and reward
- Hypothalamus: The master regulator of autonomic function, coordinating pituitary output, thermoregulation, hunger/thirst, and circadian rhythms[@coote1992]
The brainstem contains the final common pathways for autonomic control:
- Periaqueductal Gray (PAG): Coordinates defense responses, pain modulation, and vocalization
- Nucleus Tractus Solitarius (NTS): Primary visceral sensory nucleus receiving input from vagus nerve and glossopharyngeal nerve
- Dorsal Motor Nucleus of Vagus: Parasympathetic preganglionic neurons for cardiac, gastrointestinal, and pulmonary targets
- Ventrolateral Medulla: Sympathetic premotor neurons controlling vasomotor tone[@saper2002][@low2013]
The medial prefrontal cortex, anterior cingulate, insula, and amygdala form the limbic component that integrates emotional and cognitive states with autonomic responses. The mPFC exerts top-down control over subcortical autonomic structures, while the ACC monitors the internal state and detects conflicts requiring autonomic adjustment.
The insula, particularly the posterior-to-anterior gradient, processes progressively abstract representations of bodily states. Anterior insula activity correlates with conscious awareness of interoceptive signals and is crucial for generating subjective feelings such as fear, hunger, and discomfort[@critchley2005].
The hypothalamus is the master regulator of autonomic function, controlling pituitary secretion and coordinating sympathetic/parasympathetic outputs. Key hypothalamic nuclei include:
- Paraventricular Nucleus (PVN): CRH and oxytocin neurons project to brainstem autonomic centers, controlling stress responses and fluid balance
- Supraoptic Nucleus: Vasopressin neurons regulate water retention and blood pressure
- Lateral Hypothalamus: Orexin/hypocretin neurons regulate arousal, feeding, and autonomic tone
- Periaqueductal gray: Coordinates fight-or-flight responses, analgesia, and vocalization patterns
- Nucleus tractus solitarius: Receives baroreceptor, chemoreceptor, and visceral sensory input; first-order processing of cardiovascular and respiratory information
- Dorsal motor nucleus of vagus: Preganglionic parasympathetic neurons for cardiac atria, lungs, esophagus, stomach, and intestines
- Ventrolateral medulla: Contains sympathetic premotor neurons that project to spinal preganglionic neurons controlling heart, vasculature, and adrenal medulla[@saper2002]
The baroreflex is the primary mechanism for short-term blood pressure regulation. Baroreceptor afferents in the carotid sinus and aortic arch carry pressure information to the NTS. The NTS then modulates:
- Parasympathetic activation: Increases vagal tone to slow heart rate
- Sympathetic inhibition: Reduces vasomotor tone
- Hypothalamic integration: Coordinates behavioral and endocrine responses
In Parkinson's disease, baroreflex impairment contributes to orthostatic hypotension, as sympatheticnoradrenergic neurons in the ventrolateral medulla are affected by alpha-synuclein pathology[@goldstein2006][@kaufmann2002].
¶ Chemoreflex and Respiratory Control
The CAN coordinates respiratory and cardiovascular responses to changes in blood oxygen and CO2 levels. The carotid body senses hypoxemia and triggers increased ventilation and sympathetic activation through the NTS and ventrolateral medulla. This integration is relevant to sleep-disordered breathing in PD and MSA[@low2013].
The vagus nerve connects the central CAN to the enteric nervous system (ENS), often called the "second brain." This bidirectional communication explains the gut-brain axis in neurodegeneration. Alpha-synuclein pathology may initiate in the ENS and propagate retrogradely through vagal afferents to the dorsal motor nucleus—a pattern consistent with Braak staging[@braak2003][@cheng2017].
Autonomic dysfunction in Parkinson's is among the earliest and most disabling non-motor symptoms. It results from alpha-synuclein accumulation in both central autonomic structures and peripheral autonomic nerves[@orimo2008][@jost2019].
- Orthostatic Hypotension (OH): Defined as ≥20 mmHg systolic or ≥10 mmHg diastolic drop within 3 minutes of standing[@espay2014]. Present in 30-50% of PD patients, though many are asymptomatic.
- Supine Hypertension: Often coexists with OH due to baroreflex impairment and medication effects
- Reduced Heart Rate Variability (HRV): Indicates impaired vagal control[@polak2012]
- Constipation: Most common early autonomic symptom, often predating motor signs by years
- Gastroparesis: Delayed gastric emptying causing nausea and early satiety
- Dysphagia: Impaired swallowing due to vagal and glossopharyngeal involvement
¶ Other Autonomic Domains
- Urinary dysfunction: Overactive bladder, nocturia, urgency
- Sexual dysfunction: Erectile dysfunction in males
- Sudomotor dysfunction: Hypohidrosis or hyperhidrosis, thermoregulatory impairment[@kim2018][@sribvarirun2018]
Cardiac sympathetic denervation, visualized by I-123 metaiodobenzylguanidine (MIBG) scintigraphy, correlates with disease severity and provides a biomarker for peripheral autonomic involvement[@orimo2008][@jost2019]. Postganglionic norepinephrine transport is impaired due to Lewy body accumulation in sympathetic ganglia.
Severe autonomic failure is a defining feature and diagnostic criterion for MSA[@kaufmann2002][@low2013]:
- Orthostatic hypotension: ≥30 mmHg systolic or ≥15 mmHg diastolic drop (more severe than in PD)
- Urinary incontinence: Combined with orthostatic hypotension is highly specific for MSA
- Erectile dysfunction: Often severe and early
- Remote sweating abnormalities: Absent or markedly reduced sweating
- Nocturnal stridor: Due to laryngeal abductor paralysis
The pathophysiology differs from PD: MSA involves predominantly central autonomic structures (putamen, cerebellum, brainstem) rather than peripheral nerves. Cardiac sympathetic innervation is relatively preserved in MSA compared to PD[@mak2015].
Autonomic dysfunction is nearly universal in DLB and may be more severe than in PD[@fernandez2020]:
- Orthostatic hypotension: Present in up to 60% of patients
- REM sleep behavior disorder: Strong association with autonomic dysfunction
- Constipation and urinary symptoms: Common
Autonomic measures can serve as biomarkers for prodromal neurodegeneration[@postuma2015][@fernandez2020]:
- REM sleep behavior disorder (RBD): 80-90% develop synucleinopathy; autonomic dysfunction predicts conversion
- Idiopathic orthostatic hypotension: May precede PD by years
- Constipation alone: Associated with increased PD risk
- Head-up tilt test: Gold standard for orthostatic hypotension diagnosis
- Valsalva maneuver: Assesses baroreflex function and beat-to-beat blood pressure changes
- Heart rate variability: Time-domain (SDNN, RMSSD) and frequency-domain measures
- Sweat testing: Quantitative sudomotor axon reflex test (QSART)
- Biochemical markers: Plasma norepinephrine, epinephrine levels
- MIBG scintigraphy: Reduced cardiac uptake in PD (not MSA)
- I-123-FP-CIT SPECT: Assesses cardiac sympathetic innervation
- MRI: May show putaminal atrophy in MSA, iron deposition in PD
- SCOPA-AUT: Comprehensive autonomic symptom assessment
- COMPASS-SELECT: Validated for MSA and PD
- PD autonomic questionnaire: PD-specific
Orthostatic Hypotension:
- Midodrine: Alpha-1 agonist, increases venous return
- Droxidopa: Norepinephrine prodrug
- Fludrocortisone: Mineralocorticoid, expands blood volume
- Pyridostigmine: Enhances ganglionic transmission
Supine Hypertension:
- Clonidine: Central alpha-2 agonist
- Captopril: ACE inhibitor
- ** bedtime elevation**: Head of bed raised 30°
Gastrointestinal:
- Prokinetics: Metoclopramide, domperidone
- Laxatives: Polyethylene glycol, lactulose
- Increased salt and fluid intake: 2-3 L/day
- Compression stockings: Below-knee, 30-40 mmHg
- Physical counter-manuvers: Leg crossing, squatting
- Avoid large meals: Reduce postprandial hypotension
- Head-up tilt during sleep: 10-30 cm elevation[@jain2012][@mak2015]
While no therapies have proven disease-modifying effects on autonomic pathways, emerging approaches include:
- Neuroprotective agents: Targeting alpha-synuclein aggregation
- Immunotherapies: Anti-alpha-synuclein antibodies in trials
- Gene therapy: Targeting neurotrophic factors
The CAN does not operate in isolation but integrates with multiple brain networks[@mak2015]:
- Salience Network: Anterior insula and ACC form the salience network, detecting behaviorally relevant stimuli and triggering autonomic responses
- Amygdala Circuits: Emotional processing links to autonomic arousal
- Reward Circuit: Dopaminergic modulation of autonomic function
- Default Mode Network: Internal self-referential processing affects interoceptive awareness
- Brainstem arousal systems: Locus coeruleus norepinephrine and raphe serotonin systems modulate CAN function
¶ Animal Models and Experimental Findings
- 6-OHDA lesions: Reproduce sympathetic denervation
- Alpha-synuclein transgenic mice: Show autonomic dysfunction
- Lesion studies: mPFC, NTS lesions impair autonomic regulation
- Transcranial magnetic stimulation: mPFC stimulation alters HRV
- Lesion studies: Stroke in CAN regions produces autonomic dysregulation
- Neuroimaging: Functional connectivity changes in PD autonomic structures
- Biomarker development: Combining autonomic testing with neuroimaging and biochemical markers
- Early detection: Identifying prodromal cases through autonomic screening
- Mechanistic understanding: How does alpha-synuclein spread through autonomic networks?
- Targeted therapies: Developing neuroprotective strategies for autonomic pathways
- Personalized medicine: Phenotypic stratification based on autonomic dysfunction patterns
- Benarroch, E.E. (1993), The central autonomic network: functional organization, dysfunction, and perspective
- Saper, C.B. (2002), The central autonomic nervous system: conscious visceral perception and autonomic pattern generation
- Jain, S. & Goldstein, D.S. (2012), Cardiovascular dysautonomia in Parkinson disease: pathophysiology and novel therapeutic approaches
- Coote, J.H. (1992), Integration of autonomic regulation in disease
- Critchley, H.D. et al. (2004), Neural systems supporting interoceptive awareness
- Polak, T. et al. (2012), Cardiovagal and sudomotor function in early Parkinson disease
- Kim, J.B. et al. (2018), Autonomic dysfunction in Parkinson's disease: comprehensive assessment
- Sribvarirun, Y. et al. (2018), Autonomic dysfunction in Parkinson disease with orthostatic hypotension
- Goldstein, D.S. (2006), Neurocardiology: the interplay between the central and peripheral nervous systems
- Low, P.A. et al. (2013), Clinical autonomic disorders
- Kaufmann, H. et al. (2002), Orthostatic hypotension in neurodegenerative diseases
- Espay, A.J. et al. (2014), A consensus statement on the definition of orthostatic hypotension
- Jost, S.T. et al. (2019), Cardiac sympathetic denervation correlates with clinical disease severity in Parkinson disease
- Orimo, S. et al. (2008), Cardiac sympathetic denervation in Parkinson's disease
- Postuma, R.B. et al. (2015), Dopaminergic correlates of autonomic dysfunction in REM sleep behavior disorder
- Cheng, J. et al. (2017), α-Synuclein and autonomic dysfunction in Parkinson disease
- Fernandez, C.S. et al. (2020), Autonomic dysfunction in prodromal Lewy body disease
- Mak, M.K. et al. (2015), Neuroanatomy and function of the autonomic nervous system in Parkinson disease
- Tai, Y.C. & Lin, C.H. (2012), Mechanisms of neurodegeneration in Parkinson disease
- Bohnen, N.I. et al. (2009), Cholinergic and dopaminergic dysfunction in Parkinson disease
- Braak, H. et al. (2003), Staging of brain pathology related to sporadic Parkinson disease
- Kalia, L.V. & Lang, A.E. (2015), Parkinson disease
- Gelb, D.J. et al. (1999), Diagnostic criteria for Parkinson disease
- Fahn, S. (2006), Unresolved issues in Parkinson disease